Q32 Bio (QTTB) Operating Leases (2020 - 2026)

Q32 Bio's Operating Leases history runs 7 years deep, the most recent figure standing at $4.8 million for Q1 2026.

• On a quarterly basis, Operating Leases fell 13.04% year-over-year to $4.8 million in Q1 2026; TTM through Mar 2026 was $4.8 million, a 13.04% decrease from a year earlier, with the FY2025 full-year figure at $4.9 million, down 12.3% from the prior year.
• Operating Leases retreated to $4.8 million in Q1 2026 per QTTB's latest filing, from $4.9 million in the prior quarter.
• Across five years, Operating Leases topped out at $28.3 million in Q3 2022 and bottomed at $4.8 million in Q1 2026.
• The 5-year median for Operating Leases is $6.1 million (2024), against an average of $14.1 million.
• Across the five-year window, Operating Leases jumped 144.67% in 2022 and plunged 78.19% in 2024, its largest moves.
• Year by year, Operating Leases stood at $27.9 million in 2022, then tumbled by 77.62% to $6.2 million in 2023, then fell by 9.8% to $5.6 million in 2024, then retreated by 12.3% to $4.9 million in 2025, then dropped by 3.82% to $4.8 million in 2026.
• Per Business Quant, the three latest QTTB Operating Leases figures stand at $4.8 million (Q1 2026), $4.9 million (Q4 2025), and $5.1 million (Q3 2025).